Key result
Type D personality was associated with poorer medication adherence at 6 months following acute coronary syndrome.
Why the study?
Does Type D personality or its components predict medication adherence in patients following an acute coronary syndrome?
Observational (n=165)
Does Type D personality or its components predict medication adherence in patients following an acute coronary syndrome?
Negative affectivity, rather than the full Type D personality construct, is a primary predictor of poor medication adherence after acute coronary syndrome, with self-efficacy acting as a mediator.
Answers are grounded in this paper and cite their sources.
May support screening post-ACS patients for adherence risk; leaves open whether targeting Type D traits improves outcomes.
OBJECTIVE: To assess the relationship among Type D personality, self-efficacy, and medication adherence in patients with coronary heart disease. METHODS: The study design was prospective and observational. Type D personality, self-efficacy for illness management behaviors, and medication adherence were measured 3 weeks after hospitalization for acute coronary syndrome in 165 patients (mean [standard deviation] age = 61.62 [10.61] years, 16% women). Self-reported medication adherence was measured 6 months later in 118 of these patients. Multiple linear regression and mediation analyses were used to address the study research questions. RESULTS: Using the original categorical classification, 30% of patients with acute coronary syndrome were classified as having Type D personality. Categorically defined patients with Type D personality had significantly poorer medication adherence at 6 months (r = -0.29, p < .01). Negative affectivity (NA; r = -0.25, p = .01) and social inhibition (r = -0.19, p = .04), the components of Type D personality, were associated with medication adherence 6 months after discharge in bivariate analyses. There was no evidence for the interaction of NA and social inhibition, that is, Type D personality, in the prediction of medication adherence 6 months after discharge in multivariate analysis. The observed association between NA and medication adherence 6 months after discharge could be partly explained by indirect effects through self-efficacy in mediation analysis (coefficient = -0.012; 95% bias-corrected and accelerated confidence interval = -0.036 to -0.001). CONCLUSIONS: The present data suggest the primacy of NA over the Type D personality construct in predicting medication adherence. Lower levels of self-efficacy may be a mediator between higher levels of NA and poor adherence to medication in patients with coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Molloy et al. (2011) conducted an observational in acute coronary syndrome (n=165). Type D personality vs. Non-Type D personality was evaluated on medication adherence at 6 months (r = -0.29, p=<0.01). Type D personality was associated with poorer medication adherence at 6 months following acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: